Israel is the world leader in patents for medical devices, relative to population size, and second in the patenting of biopharm products, including pharmaceuticals and treatments.
Israel is eighth in the number of patents granted in the life-sciences industry, which may be the most amazing statistic of all, given the amount of time and money companies must invest in getting a product or technology tested and patented.
This week, the Israeli biotech industry was having its annual conference, the Biomed Israel 2011 show, sponsored by the Life Sciences Industries Association in Israel (ILSI), a nonprofit organization founded to serve and promote the goals of the Israeli life-sciences industry in the international arena. The show, which is taking place in Tel Aviv and is celebrating its tenth anniversary, has become a can’t-miss affair for top executives of pharmaceutical and medical-technology giants around the world.
So how successful has the Israeli life sciences industry been? Check out the stats: There are currently about 700 active life-sciences companies in Israel; 56 percent of them (396) of them were founded in the last decade.
A quarter of them, 173, were founded only five years ago. Of the rest, 306 were founded before 2001, with the oldest, Teva Pharmaceuticals, founded in 1901 (amazing but true). Out of the 700, 401 (56%) are in the medicaldevices business.
From 2001 to 2005 the industry’s annual growth was 12%. Even though things have slowed a bit over the past three years, Biomed organizing committee chairperson Ruti Alon says growth has returned to the sector.
More than 100 of the companies established over the last decade are making money, she says, and “the most impressive fact is that 25 companies, about 8% of all companies that produce income, were founded only five years ago.”
Some testimonials as for ILSI- Biomed Israel 2011:
“Back to Paris I would like to thank you for the excellence of the organization and the quality of the Company we have met. We learned a lot and see several opportunities to partner with Israeli Biotech Companies”
- Philippe Goupit, Sanofi-Aventis, Business Development Corporate Licenses
“I would like to thank you very much for giving me the opportunity to talk about EU reimbursement during ILSI Biomed in Tel Aviv. I was impressed by the fantastic organization of the program and the conference itself.
It would be a very great pleasure for me to participate again next year”
- Dr. Hubertus Rosery MPH (CEO), AiM GmbH, Assessment in Medicine Research and Consulting
“Thanks for the nice introduction; I had a number of meetings and feel that I am slowly getting to know the needs and interests of the many wonderful technology companies born in Israel. Congratulations on a very successful conference!”
- Dan Mendelson, CEO, Avalere Health LLC
Really excellent. Well planned. Very nice atmosphere.
Key-note speakers were the best. Cocktail party was a delight.
Kenes did a great job. Kol Hakavod to ILSI & Ruti.
- David Blum
Popularity: 47% [?]